NCT01653639 - Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Hemophilia A

Interventions

BIOLOGICAL

Recombinant Factor VIII (Kogenate FS, BAY14-2222)

50 IU/kg single dose using the 3000 IU vial size (600 IU/ml)

BIOLOGICAL

Recombinant Factor VIII (Kogenate FS, BAY14-2222)

50 IU/kg single dose using the 2000 IU vial size (400 IU/ml)

Trial Locations (1)

Sofia